1. Home
  2. XRTX vs NBY Comparison

XRTX vs NBY Comparison

Compare XRTX & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XRTX
  • NBY
  • Stock Information
  • Founded
  • XRTX 2011
  • NBY 2000
  • Country
  • XRTX Canada
  • NBY United States
  • Employees
  • XRTX N/A
  • NBY N/A
  • Industry
  • XRTX Pharmaceuticals and Biotechnology
  • NBY
  • Sector
  • XRTX Health Care
  • NBY
  • Exchange
  • XRTX Nasdaq
  • NBY Nasdaq
  • Market Cap
  • XRTX 3.0M
  • NBY 2.8M
  • IPO Year
  • XRTX N/A
  • NBY 2007
  • Fundamental
  • Price
  • XRTX $0.92
  • NBY $0.64
  • Analyst Decision
  • XRTX
  • NBY Strong Buy
  • Analyst Count
  • XRTX 0
  • NBY 1
  • Target Price
  • XRTX N/A
  • NBY $0.85
  • AVG Volume (30 Days)
  • XRTX 84.2K
  • NBY 72.4K
  • Earning Date
  • XRTX 05-09-2025
  • NBY 03-25-2025
  • Dividend Yield
  • XRTX N/A
  • NBY N/A
  • EPS Growth
  • XRTX N/A
  • NBY N/A
  • EPS
  • XRTX N/A
  • NBY N/A
  • Revenue
  • XRTX N/A
  • NBY $13,844,000.00
  • Revenue This Year
  • XRTX N/A
  • NBY N/A
  • Revenue Next Year
  • XRTX N/A
  • NBY $11.73
  • P/E Ratio
  • XRTX N/A
  • NBY N/A
  • Revenue Growth
  • XRTX N/A
  • NBY 15.40
  • 52 Week Low
  • XRTX $0.82
  • NBY $0.36
  • 52 Week High
  • XRTX $5.81
  • NBY $9.10
  • Technical
  • Relative Strength Index (RSI)
  • XRTX 42.89
  • NBY 42.79
  • Support Level
  • XRTX $0.85
  • NBY $0.55
  • Resistance Level
  • XRTX $1.10
  • NBY $0.61
  • Average True Range (ATR)
  • XRTX 0.11
  • NBY 0.04
  • MACD
  • XRTX 0.00
  • NBY -0.00
  • Stochastic Oscillator
  • XRTX 11.63
  • NBY 27.23

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.

Share on Social Networks: